logo
Udderly relaxed: How massaging newborn calves might make them heavier, healthier

Udderly relaxed: How massaging newborn calves might make them heavier, healthier

CBC2 days ago
When calving season rolls around, cattle rancher Karyn Neilson doubles as a masseuse.
She gives every other newborn calf on her central Alberta farm a one-minute, head-to-hoof massage — hoping it'll be the start of a healthier and more profitable herd.
"We do that to imitate what its mother will do and create a positive bond with the animal," said Neilson, co-owner of Neilson Beef in Stettler, Alta.
"In future interactions we have with it, it won't be viewing us as a predator. It has a positive interaction with us and then it's just easier to handle and such in the future."
Using gentle but firm pressure, she starts the spa treatment at the top of the calf's head before moving down their backs and legs, while keeping an eye on their tail.
"When you can hit a spot where their tails wag, you can tell you're making them extra happy."
Neilson has done this to hundreds of newborn calves in the last five years, as part of a research study with Olds College.
They're looking to see if using this technique in the first week of life — a critical period of brain development — can reduce the calves' stress, make them healthier and heavier, and ultimately help beef producers make more money.
47-pound weight gain
Lead researcher Désirée Gellatly compares the technique, known more formally as tactile stimulation, to skin-to-skin contact with newborn human babies.
"The first time [producers] interact with the beef calf is normally averse — it's to do ear tagging, it's to do shots, it's to do castration. We are trying to see if with one minute of gentle touch at the time of processing the calf, we can switch how the calf perceives us," said Gellatly, research scientist for Olds College's Technology Access Centre for Livestock Production.
Inspired by a similar study she worked on with dairy calves in Brazil, she's also hoping to improve calves' health.
Between Neilson Beef and another cattle ranch in southern Alberta, Gellatly is set to analyze data from roughly 900 animals next month.
She said the initial pilot study, conducted over two years starting in 2020, showed some positive signs.
"We found in the first year that animals that received the massage were 47 pounds heavier than animals that did not receive the massage," she said.
"In the second year, we found they were about 20 pounds heavier than animals that did not receive the massage."
This year, the researchers and producers are conducting DNA testing to rule out whether the sire's genetics are contributing to the weight differences. Gellatly and her research team plan to submit their scientific paper in the next couple of months.
"The goal is that producers start doing this not only because it can improve the profitability, but because it's the right thing to do, right? We are taking care of these animals. We are using these animals. So I think it's fair with them that we treat them right."
$150 a minute
With nearly 15,000 followers on TikTok, sharing this novel approach has been met with some skepticism by other producers.
But for Lance Neilson, Karyn's husband, the extra time spent is worth it.
"Right now, a calf is worth, say, about $5 a pound when you wean them from their mother. So if you're getting an extra 30 lbs., we're talking $150 for a minute of work," he said.
"$150 a minute — that's a pretty good payday for you."
He said massages alone aren't magic, but the bond formed sets the stage to layer on other low-stress handling techniques throughout the cows' lives.
The Neilsons say it has also reduced their stress.
"We are calmer. The cows are calmer…. We don't groan if we have to go to do cows like maybe we did five or six years ago," said Karyn.
Low-stress handling
Near Nanton, Alta., John Smith and Laura Laing of Platteau Cattle Co. — winners of this year's environmental stewardship award from Alberta Beef Producers — also joined the study two years ago, in a relentless pursuit of improving their cattle's welfare.
They said they receive similar pushback, but also a lot of comments from curious folks. They say the credibility is ultimately in the research.
"There's a lot of factors and some of those things are really hard to account for. But I know from boots on the ground, what we see is … something good happens when you do it. And I think any producer, if they took the time, the 60 seconds, they would feel the same thing that we feel," said Smith.
Laing said the biggest challenge they face is not massaging all of the cows because they're still in the study and need a control group.
That's going to change once the data collection stage is over.
"We're just going to massage every calf," said Smith.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program
Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program

National Post

time22 minutes ago

  • National Post

Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program

New Ontario Drug Benefit (ODB) coverage means eligible Ontarians who take insulin can now benefit from using Dexcom G7 to simplify management of their diabetes. Article content BURNABY, British Columbia — Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, applauds the Ontario government for its recent decision to include the Dexcom G7 Continuous Glucose Monitoring (CGM) System as part of the Ontario Drug Benefit (ODB) program for eligible Ontarians who manage their diabetes with insulin.* Article content Article content Diabetes Canada estimates that 1.7 million people in Ontario are living with diabetes in 2024, with a significant portion requiring insulin for either type 1 or type 2 diabetes 1. This highlights a broad need for support across both types of diabetes for insulin therapy optimization. Article content This coverage expansion will grant access to Dexcom G7 to a broader population and make Dexcom G7 now the most covered CGM on government-funded programs in Ontario †,2 for people on insulin through the following programs: Article content Ontario Drug Benefit (ODB) Article content – for eligible residents on insulin aged 65+ or earlier if they: Article content Live in a long-term care home, home for special care, or Community Home for Opportunity Are 24 or under without private insurance (OHIP+) Receive professional home and community care Get benefits from Ontario Works or ODSP Are enrolled in the Trillium Drug Program Article content – for individuals with type 1 diabetes who meet the eligibility criteria. Article content Private Insurance Article content – most private insurance plans cover Dexcom G7 for anyone on insulin. Article content – for eligible First Nations and Inuit clients on insulin. Article content 'This announcement represents a significant step forward for people managing diabetes in Ontario and their healthcare providers with more equitable access to Dexcom's life-changing CGM technology,' says André Côté, Vice President and General Manager of Dexcom Canada. 'By expanding coverage for Dexcom G7 under ODB, Ontario is recognizing the value of the #1 preferred glucose sensor by Canadian endocrinologists ‡, 3 for the management of insulin-using patients.' Article content Dexcom G7 is the most accurate CGM with clinically proven outcomes §,2 including lowering A1C, reducing hyper-and hypoglycemia, and increasing time in range for people with type 1 or type 2 diabetes 4-8. Featuring several unique alerts supporting safer insulin therapy, this increased access to Dexcom G7 is welcome news for both healthcare providers and their patients using insulin. Article content 'As an endocrinologist, I've seen firsthand how continuous glucose monitoring has transformed diabetes management,' says Dr. Alexander Abitbol, Endocrinologist & Assistant Medical Director, LMC Healthcare. 'Managing diabetes is very personal, and being able to offer patients a choice on the most appropriate CGM technology with features tailored to help them meet their individualized care goals is critical.' Article content Dexcom G7 allows individuals to easily see their glucose levels in real-time to make more informed insulin treatment decisions. Users can see directly how medications affect their levels and gain insights on what keeps their levels stable, empowering them to learn what works in order to feel their best and stay motivated over time. Article content Discreet and easy to use, Dexcom G7 is the only sensor in Canada to offer these features for insulin therapy optimization and personalization for any lifestyle: Article content As the #1 patient recommended CGM in Canada ††,12, Dexcom G7 delivers both clinical and lifestyle benefits, and now more Ontarians than ever will have access to this technology for their diabetes management. Article content To learn more about Dexcom G7 and the public and private coverage options available, please visit About Dexcom Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in continuous glucose monitoring for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently. Article content _______________________________________ * For ODB eligible persons who are on insulin therapy for diabetes and who have a valid prescription for Dexcom G7 from a physician or nurse practitioner. Limit of 45 Dexcom G7 Sensors per eligible person per 365-day period. Dexcom G7 Receivers are also covered if there is no compatible smart device. For detailed coverage criteria, please visit † Dexcom G7 is the only CGM covered by ODB, ADP, most private insurance & NIHB for people on insulin. Eligibility and coverage vary by policy, plan, and payor. For insurance assistance call Dexcom Canada at 1-844-832-1810 with any questions. ‡ Based on a survey of Canadian Endocrinologists (n=41) § When compared with CGM systems commercially available in Canada as of October, 2023. Sensors worn on the back of the upper arm have been found to be slightly more accurate than sensors worn on the abdomen. || Audible and visual notification of predictive alert at 3.1 mmol/L within 20 minutes. ¶ The Dexcom G7 Sensor is waterproof and may be submerged under eight feet of water for up to 24 hours without failure when properly installed. # Indicated for wear on the back of the upper arm and abdomen for ages 2 years and older or the upper buttocks for ages 2-6 years old. ** Smart device sold separately. To view a list of compatible devices, visit Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. †† Based on a comparison in NPS scores across major CGM brands 1 2 Dexcom, data on file, 2025 3 Q&A, Dexcom Canadian Endos Report Wave 1 2024 4 Beck, RW, et al. JAMA. 2017;317(4):371-378. 5 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 6 Martens T, et al. JAMA. 2021;325(22):2262-2272. 7 Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 8 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7. 9 Dexcom G7 User Guide. 10 Aly A, et al. Diabetes Technol. Ther. 2024;26(S2): A254-255. 11 Puhr S, et al. Diabetes Technol Ther. 2019;21(4):155-158. 12 DQ&A, Canada Diabetes Connections Patient Panel Report, H1 2024 Article content Article content Article content Article content Article content Contacts Article content Media Contact: Article content Article content Cole Douglas Article content Article content Article content

Kids under 12 in Alberta face months-long gap in COVID vaccine availability
Kids under 12 in Alberta face months-long gap in COVID vaccine availability

CBC

timean hour ago

  • CBC

Kids under 12 in Alberta face months-long gap in COVID vaccine availability

Shuhiba Mohammad recently took her daughter for her routine childhood immunizations at age 1, and was frustrated when she was told she'd have to book a separate appointment to get a COVID vaccine. Then, when she called Alberta Health Service's 811 phone number to book an appointment, she learned her child couldn't get a COVID shot, at all. "I was on the phone for about 45 minutes and somebody got back to me that the Moderna vaccine — that was the COVID vaccine given to children under the age of 12 — was expired as of June 17 ... and so there is no opportunity to vaccinate a child under 12 for COVID until the fall," she said. "So we're kind of in a little bit of a limbo, where she's going to have no immunity to COVID and we've just started daycare." Mohammad says she would have appreciated some kind of heads up or communication about this from public health officials, but actually received the opposite when she brought her daughter to her six-month routine immunization appointment. "They had said that we will deal with the COVID vaccines at a year of age," Mohammed said. "But now that I went and I looked it up and I dug into it a little bit deeper, I could have gotten her a vaccine at six months, but public health had told me a year." The AHS vaccine-booking website now informs visitors: "COVID-19 vaccine for individuals 6 months up to and including 11 years of age expired June 17, 2025. After this date, COVID-19 vaccine will only be available for eligible individuals 12 years of age and older." But that warning did not appear in an earlier version of the website, captured on June 14 by the Wayback Machine. Adult vaccines about to be pulled, too An AHS spokesperson declined to answer questions about the vaccine availability, referring them instead to the province's newly created Ministry of Primary and Preventative Health Services, headed up by former health minister Adriana LaGrange. An official with the ministry told CBC News in an email the Moderna COVID-19 vaccine "is currently unavailable across Canada, as all remaining doses have expired" and new doses for children aged six months and older are expected "in the fall." Adults, too, will also soon be ineligible to receive the current batch of COVID shots. "The KP.2 COVID-19 vaccine will no longer be administered in Alberta after July 31, as the province prepares to introduce a new formulation this fall," the official said. "Most remaining KP.2 doses are nearing expiry, and removing them now helps ensure a smooth transition to the new prefilled syringe formulation, which also requires different storage and planning." Craig Jenne, a professor in the department of microbiology, immunology and infectious diseases at the University of Calgary, said it's "frustrating" that children, in particular, will have a months-long gap in vaccine availability. "We have to appreciate that maybe, at a population level, the kids are less at risk of severe COVID, but we do know that the youngest ones are at risk of intensive care unit admission," he said. "So, the fact that this is a Health Canada-approved vaccine, we know it works, we know it's safe, but it's simply not available is really frustrating from the public health level." 'We've got to jump through multiple hoops' Jenne said from a public health perspective, the goal is generally to make vaccines as easily available as possible. "What we've seen with COVID is the exact opposite," he said. He worries about the provincial government's plan to starting charging Albertans a fee for COVID vaccines, once new doses arrive in the fall, and to require people to pre-register to receive them at specialized immunization clinics, because the province will no longer make them available at pharmacies. "So this is now a vaccine that we've got to jump through multiple hoops for — including a significant cost barrier to some Albertans — and there's no doubt that this will drive down uptake and leave a percentage of Albertans who may otherwise want to be protected unable to access the vaccine," Jenne said. In announcing the plans to reduce availability and start charging for the vaccine, the government of Alberta cited COVID immunization advice from the United States. "Recently, the Federal Drug Administration in the United States stopped recommending routine COVID-19 vaccines for pregnant women and healthy children," the province said in a June 13 press release. That change had been announced in May by U.S. Health and Human Services Secretary Robert F. Kennedy Jr. and runs contrary to the latest vaccine guidance in Canada. Starting Aug. 11, the province plans to launch a new "pre-order tool" through its vaccine-booking system where Albertans can "express interest" in receiving both the COVID and influenza vaccines. "Those who pre-order will receive a reminder by text or email prompting them to book their appointment in early October. Pre-ordering is being used to help plan for vaccine needs and reduce potential waste," the ministry official said. "Due to recent changes to the federal COVID-19 vaccine procurement process, provinces and territories are now responsible for purchasing COVID-19 vaccines for residents. Alberta's government remains committed to ensuring Albertans at highest risk of severe outcomes from COVID-19 have access to immunizations." Most Albertans will have to pay for the COVID shot in the fall but the price has not yet been announced. Flu vaccines will remain free, the ministry official said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store